Q1 2026 Eris Lifesciences Ltd Earnings Call Transcript
(audio in progress) -- earnings conference call of Eris Life Sciences. Mr. Amit Bakshi, Chairman and managing Director, Mr. V. Krishna Kumar, Chief Operating Officer and Executive Director; Mr. Sachin Shah, Chief Financial Officer; and Ms. Kruti Raval, Vice President, M&A and Investor Relations.
(Operator Instructions) Please note this call is being recorded.
I would now like to hand the conference over to Mr. V. Krishna Kumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Thank you. Good evening, everybody, and welcome to our Q1 earnings call.
So to get started the key highlights of the quarter, the Domestic Branded business segment, which is now representing the fully integrated segment consisting of all acquisitions, it has grown 11% this quarter, thereby outperforming the IPM by 330 basis points. And if we exclude the impact from discontinued FDCs and some insulin shortages we've
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
